State Corporation Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have s...
Health services organization Cigna has launched Cigna Ventures, a corporate venture fund with an infusion of $250 millio...
Singapore – Fullerton Healthcare Corporation announced that its wholly owned subsidiaries, Fullerton Health P...
Systech, a global technology leader in brand protection and product authentication, and FarmaTrust, a leader in pharmace...
A group of scientists at the University of Manchester, UK has developed the first non-antibiotic drug to successfully tr...
Genesys Spine is pleased to announce the FDA clearance of our latest product line, the AIS-C Stand-Alone System. The AI...
Singapore - BloodCenter of Wisconsin, part of Versiti, is among four academic and research centers which will recei...
Singapore - The UK's National Institute for Health and Care Excellence rejected Roche's OCREVUS (ocrelizumab) for p...
Singapore - Medivir AB announced it has appointed Linda Basse as Chief Medical Officer effective October ...
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
Dean Maglaris, CEO of Cytogel Pharma has announced that Alan W. Dunton, M.D. has been named to the Board of Cytogel.&nbs...
Samsung Electronics is all set to open a new artificial intelligence (AI) research centre in New York City, U.S., to str...
LimaCorporate, a pioneer and leader in a 3D printing of Orthopaedic implants, announces the milestone-based acquisition ...
The Healthcare Businesswomen’s Association (HBA) has announced that twelve prominent healthcare and life science c...
Westlake Village BioPartners, a new venture firm exclusively focused on investing in life sciences has announced the lau...
AGC Biologics, a contract development and manufacturing organization specializing in the clinical and commercial manufac...
Ares Genetics, a division of German molecular diagnostics company Curetis, has initiated the development of a new diagno...
Active Biotech has announced that it regains the global development and commercialization rights to laquinimod from...
